Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,091 | -10,350 | -14,859 | -9,951 | -5,776 |
| Depreciation Amortization | 7,101 | 3,551 | 14,487 | 10,821 | 7,326 |
| Income taxes - deferred | -3,277 | -2,373 | -5,270 | -3,491 | -2,020 |
| Accounts receivable | -2,116 | 4,057 | -5,630 | -4,983 | -3,103 |
| Accounts payable and accrued liabilities | -1,029 | -713 | 1,965 | 533 | 284 |
| Other Working Capital | -12,952 | 642 | -11,378 | -9,355 | -6,584 |
| Other Operating Activity | 13,453 | 1,568 | 25,094 | 20,354 | 11,092 |
| Operating Cash Flow | $-11,911 | $-3,618 | $4,409 | $3,928 | $1,219 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,846 | -1,389 | -7,486 | -4,957 | -3,266 |
| Investing Cash Flow | $-2,846 | $-1,389 | $-7,486 | $-4,957 | $-3,266 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -284 | -284 | -53 |
| Common Stock Issued | 37 | 7 | 16 | 15 | 15 |
| Common Stock Repurchased | -5,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,593 | -1,620 | -4,584 | -5,250 | -870 |
| Financing Cash Flow | $-6,556 | $-1,613 | $-4,852 | $-5,519 | $-908 |
| Exchange Rate Effect | 57 | 30 | -130 | -61 | -39 |
| Beginning Cash Position | 86,327 | 86,327 | 94,386 | 94,386 | 94,386 |
| End Cash Position | 65,071 | 79,737 | 86,327 | 87,777 | 91,392 |
| Net Cash Flow | $-21,256 | $-6,590 | $-8,059 | $-6,609 | $-2,994 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,911 | -3,618 | 4,409 | 3,928 | 1,219 |
| Capital Expenditure | -2,846 | -1,389 | -7,486 | -4,957 | -3,266 |
| Free Cash Flow | -14,757 | -5,007 | -3,077 | -1,029 | -2,047 |